Spinal disinhibition in experimental and clinical painful diabetic neuropathy

Andrew G. Marshall, Corinne Lee-Kubli, Shazli Azmi, Michael Zhang, Maryam Ferdousi, Teresa Mixcoatl-Zecuatl, Ioannis N. Petropoulos, Georgios Ponirakis, Mark S. Fineman, Hassan Fadavi, Katie Frizzi, Mitra Tavakoli, Maria Jeziorska, Corinne G. Jolivalt, Andrew J.M. Boulton, Nathan Efron, Nigel A. Calcutt, Rayaz Malik

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Impaired rate-dependent depression (RDD) of the Hoffman reflex is associated with reduced dorsal spinal cord potassium chloride cotransporter expression and impaired spinal γ-aminobutyric acid type A receptor function, indicative of spinal inhibitory dysfunction. We have investigated the pathogenesis of impaired RDD in diabetic rodents exhibiting features of painful neuropathy and the translational potential of this marker of spinal inhibitory dysfunction in human painful diabetic neuropathy. Impaired RDD and allodynia were present in type 1 and type 2 diabetic rats but not in ratswith type 1 diabetes receiving insulin supplementation that did not restore normoglycemia. Impaired RDD in diabetic rats was rapidly normalized by spinal delivery of duloxetine acting via 5-hydroxytryptamine type 2A receptors and temporally coincident with the alleviation of allodynia. Deficits in RDD and corneal nerve density were demonstrated in patients with painful diabetic neuropathy compared with healthy control subjects and patients with painless diabetic neuropathy. Spinal inhibitory dysfunction and peripheral small fiber pathology may contribute to the clinical phenotype in painful diabetic neuropathy. Deficits in RDD may help identify patients with spinallymediated painful diabetic neuropathy who may respond optimally to therapies such as duloxetine.

Original languageEnglish
Pages (from-to)1380-1390
Number of pages11
JournalDiabetes
Volume66
Issue number5
DOIs
Publication statusPublished - 1 May 2017

Fingerprint

Diabetic Neuropathies
Hyperalgesia
Aminobutyrates
Abnormal Reflexes
Serotonin Receptors
Type 1 Diabetes Mellitus
Rodentia
Spinal Cord
Healthy Volunteers
Insulin
Pathology
Phenotype
Duloxetine Hydrochloride

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Marshall, A. G., Lee-Kubli, C., Azmi, S., Zhang, M., Ferdousi, M., Mixcoatl-Zecuatl, T., ... Malik, R. (2017). Spinal disinhibition in experimental and clinical painful diabetic neuropathy. Diabetes, 66(5), 1380-1390. https://doi.org/10.2337/db16-1181

Spinal disinhibition in experimental and clinical painful diabetic neuropathy. / Marshall, Andrew G.; Lee-Kubli, Corinne; Azmi, Shazli; Zhang, Michael; Ferdousi, Maryam; Mixcoatl-Zecuatl, Teresa; Petropoulos, Ioannis N.; Ponirakis, Georgios; Fineman, Mark S.; Fadavi, Hassan; Frizzi, Katie; Tavakoli, Mitra; Jeziorska, Maria; Jolivalt, Corinne G.; Boulton, Andrew J.M.; Efron, Nathan; Calcutt, Nigel A.; Malik, Rayaz.

In: Diabetes, Vol. 66, No. 5, 01.05.2017, p. 1380-1390.

Research output: Contribution to journalArticle

Marshall, AG, Lee-Kubli, C, Azmi, S, Zhang, M, Ferdousi, M, Mixcoatl-Zecuatl, T, Petropoulos, IN, Ponirakis, G, Fineman, MS, Fadavi, H, Frizzi, K, Tavakoli, M, Jeziorska, M, Jolivalt, CG, Boulton, AJM, Efron, N, Calcutt, NA & Malik, R 2017, 'Spinal disinhibition in experimental and clinical painful diabetic neuropathy', Diabetes, vol. 66, no. 5, pp. 1380-1390. https://doi.org/10.2337/db16-1181
Marshall AG, Lee-Kubli C, Azmi S, Zhang M, Ferdousi M, Mixcoatl-Zecuatl T et al. Spinal disinhibition in experimental and clinical painful diabetic neuropathy. Diabetes. 2017 May 1;66(5):1380-1390. https://doi.org/10.2337/db16-1181
Marshall, Andrew G. ; Lee-Kubli, Corinne ; Azmi, Shazli ; Zhang, Michael ; Ferdousi, Maryam ; Mixcoatl-Zecuatl, Teresa ; Petropoulos, Ioannis N. ; Ponirakis, Georgios ; Fineman, Mark S. ; Fadavi, Hassan ; Frizzi, Katie ; Tavakoli, Mitra ; Jeziorska, Maria ; Jolivalt, Corinne G. ; Boulton, Andrew J.M. ; Efron, Nathan ; Calcutt, Nigel A. ; Malik, Rayaz. / Spinal disinhibition in experimental and clinical painful diabetic neuropathy. In: Diabetes. 2017 ; Vol. 66, No. 5. pp. 1380-1390.
@article{6473bd6a5a764e49b36779349538df19,
title = "Spinal disinhibition in experimental and clinical painful diabetic neuropathy",
abstract = "Impaired rate-dependent depression (RDD) of the Hoffman reflex is associated with reduced dorsal spinal cord potassium chloride cotransporter expression and impaired spinal γ-aminobutyric acid type A receptor function, indicative of spinal inhibitory dysfunction. We have investigated the pathogenesis of impaired RDD in diabetic rodents exhibiting features of painful neuropathy and the translational potential of this marker of spinal inhibitory dysfunction in human painful diabetic neuropathy. Impaired RDD and allodynia were present in type 1 and type 2 diabetic rats but not in ratswith type 1 diabetes receiving insulin supplementation that did not restore normoglycemia. Impaired RDD in diabetic rats was rapidly normalized by spinal delivery of duloxetine acting via 5-hydroxytryptamine type 2A receptors and temporally coincident with the alleviation of allodynia. Deficits in RDD and corneal nerve density were demonstrated in patients with painful diabetic neuropathy compared with healthy control subjects and patients with painless diabetic neuropathy. Spinal inhibitory dysfunction and peripheral small fiber pathology may contribute to the clinical phenotype in painful diabetic neuropathy. Deficits in RDD may help identify patients with spinallymediated painful diabetic neuropathy who may respond optimally to therapies such as duloxetine.",
author = "Marshall, {Andrew G.} and Corinne Lee-Kubli and Shazli Azmi and Michael Zhang and Maryam Ferdousi and Teresa Mixcoatl-Zecuatl and Petropoulos, {Ioannis N.} and Georgios Ponirakis and Fineman, {Mark S.} and Hassan Fadavi and Katie Frizzi and Mitra Tavakoli and Maria Jeziorska and Jolivalt, {Corinne G.} and Boulton, {Andrew J.M.} and Nathan Efron and Calcutt, {Nigel A.} and Rayaz Malik",
year = "2017",
month = "5",
day = "1",
doi = "10.2337/db16-1181",
language = "English",
volume = "66",
pages = "1380--1390",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Spinal disinhibition in experimental and clinical painful diabetic neuropathy

AU - Marshall, Andrew G.

AU - Lee-Kubli, Corinne

AU - Azmi, Shazli

AU - Zhang, Michael

AU - Ferdousi, Maryam

AU - Mixcoatl-Zecuatl, Teresa

AU - Petropoulos, Ioannis N.

AU - Ponirakis, Georgios

AU - Fineman, Mark S.

AU - Fadavi, Hassan

AU - Frizzi, Katie

AU - Tavakoli, Mitra

AU - Jeziorska, Maria

AU - Jolivalt, Corinne G.

AU - Boulton, Andrew J.M.

AU - Efron, Nathan

AU - Calcutt, Nigel A.

AU - Malik, Rayaz

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Impaired rate-dependent depression (RDD) of the Hoffman reflex is associated with reduced dorsal spinal cord potassium chloride cotransporter expression and impaired spinal γ-aminobutyric acid type A receptor function, indicative of spinal inhibitory dysfunction. We have investigated the pathogenesis of impaired RDD in diabetic rodents exhibiting features of painful neuropathy and the translational potential of this marker of spinal inhibitory dysfunction in human painful diabetic neuropathy. Impaired RDD and allodynia were present in type 1 and type 2 diabetic rats but not in ratswith type 1 diabetes receiving insulin supplementation that did not restore normoglycemia. Impaired RDD in diabetic rats was rapidly normalized by spinal delivery of duloxetine acting via 5-hydroxytryptamine type 2A receptors and temporally coincident with the alleviation of allodynia. Deficits in RDD and corneal nerve density were demonstrated in patients with painful diabetic neuropathy compared with healthy control subjects and patients with painless diabetic neuropathy. Spinal inhibitory dysfunction and peripheral small fiber pathology may contribute to the clinical phenotype in painful diabetic neuropathy. Deficits in RDD may help identify patients with spinallymediated painful diabetic neuropathy who may respond optimally to therapies such as duloxetine.

AB - Impaired rate-dependent depression (RDD) of the Hoffman reflex is associated with reduced dorsal spinal cord potassium chloride cotransporter expression and impaired spinal γ-aminobutyric acid type A receptor function, indicative of spinal inhibitory dysfunction. We have investigated the pathogenesis of impaired RDD in diabetic rodents exhibiting features of painful neuropathy and the translational potential of this marker of spinal inhibitory dysfunction in human painful diabetic neuropathy. Impaired RDD and allodynia were present in type 1 and type 2 diabetic rats but not in ratswith type 1 diabetes receiving insulin supplementation that did not restore normoglycemia. Impaired RDD in diabetic rats was rapidly normalized by spinal delivery of duloxetine acting via 5-hydroxytryptamine type 2A receptors and temporally coincident with the alleviation of allodynia. Deficits in RDD and corneal nerve density were demonstrated in patients with painful diabetic neuropathy compared with healthy control subjects and patients with painless diabetic neuropathy. Spinal inhibitory dysfunction and peripheral small fiber pathology may contribute to the clinical phenotype in painful diabetic neuropathy. Deficits in RDD may help identify patients with spinallymediated painful diabetic neuropathy who may respond optimally to therapies such as duloxetine.

UR - http://www.scopus.com/inward/record.url?scp=85019387957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019387957&partnerID=8YFLogxK

U2 - 10.2337/db16-1181

DO - 10.2337/db16-1181

M3 - Article

VL - 66

SP - 1380

EP - 1390

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -